436Tip COLSTAR: Randomized, Open-Label, Multicentre, Phase III Study Comparing Futuximab/modotuximab Plus Trifluridine/tipiracil to Trifluridine/tipiracil in KRAS/NRAS and BRAF Wild Type (wt) Metastatic Colorectal Cancer (mcrc) Previously Treated with Both Standard and Anti-Egfr Treatment
Annals of Oncology（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined